Lexapro During Pregnancy and Breastfeeding

Is Lexapro Safe During Pregnancy?

Lexapro (escitalopram) is one of two antidepressants the American College of Obstetricians and Gynecologists (ACOG) names as a reasonable first-line choice for depression or anxiety during pregnancy when someone has not taken an antidepressant before, alongside sertraline (Zoloft).

The research on escitalopram in pregnancy is generally reassuring but thinner than for sertraline. ACOG’s endorsement is based partly on how well escitalopram works and how well people tolerate it, rather than on evidence that it is safer in pregnancy. For the full picture, see antidepressants during pregnancy.

Lexapro and Birth Defects

About 3 in 100 babies have a birth defect regardless of medication.

  • According to MotherToBaby, most studies have not found that escitalopram or citalopram increases the chance of birth defects.
  • Some studies have reported possible heart defect links, but MotherToBaby notes most of those studies have flaws that make it hard to know whether the medication or other factors were responsible.
  • Escitalopram is the active form of citalopram (Celexa). A few studies found a small increase in birth defects with citalopram, but it is not known whether that applies to escitalopram, which has less study data of its own.

Across SSRIs as a class, the largest studies that account for depression itself or compare siblings have not found a meaningful increase in birth defects.

Other Pregnancy Risks

  • Miscarriage: a study of citalopram and escitalopram did not find an increased chance of miscarriage.
  • Preterm birth and low birth weight: some studies suggest a higher chance with use throughout pregnancy, but depression itself is also linked to both, making the cause hard to separate.
  • PPHN (a rare newborn lung condition): the overall chance with SSRIs is under 1%, and an analysis cited by ACOG ranked escitalopram second-least likely among SSRIs to be associated with it, after sertraline.
  • Newborn adaptation symptoms: some babies exposed late in pregnancy have mild symptoms such as jitteriness or feeding problems, which usually go away within a couple of weeks. Some babies may need extra time in the nursery. Stopping before delivery is not recommended.
  • Autism and ADHD: most studies have not found an increased chance once other factors are accounted for.

Is Lexapro Category C?

Lexapro was labeled “Pregnancy Category C” before the FDA removed pregnancy letter categories in 2015 for being confusing and overly simplistic. Zoloft, Prozac and Wellbutrin were Category C as well, so the letter never meant Lexapro was riskier or safer than they are.

Should You Keep Taking Lexapro If You Get Pregnant?

  • ACOG recommends against stopping mental health medication because of pregnancy alone.
  • If escitalopram has worked for you, ACOG says a previously effective medication should generally be the choice.
  • Women who stopped antidepressants during pregnancy relapsed far more often (68%) than those who continued (26%) in one well-known study.
  • Do not stop suddenly. Abrupt stopping can cause withdrawal symptoms; plan any change with your prescriber.

Lexapro and Breastfeeding

According to the NIH’s LactMed database, escitalopram is not a reason to stop breastfeeding.

  • Doses up to 20 mg a day produce low levels in breast milk. Studies estimate the baby receives about 2.6% to 3.9% of the mother’s weight-adjusted dose.
  • Escitalopram was undetectable in the blood of breastfed babies tested in one study.
  • No developmental harm has been found in children followed for up to 5 years.
  • LactMed advises watching the baby for excess drowsiness, restlessness, agitation, poor feeding and poor weight gain, especially in younger, exclusively breastfed babies and when other psychiatric medications are also used.
  • Harm is not expected, especially once the baby is older than 2 months. Isolated case reports of problems in newborns exist, but they have not been shown to be caused by the medication.

If escitalopram kept you well during pregnancy, ACOG advises not switching medications after birth, because your baby’s exposure during pregnancy was far greater than through breast milk. You do not need to pump and dump, and routine blood tests for the baby are not recommended without a specific concern.

Does Lexapro Affect Milk Supply?

There is no strong evidence that escitalopram reduces milk supply. SSRIs can occasionally raise prolactin, and one small study found milk came in about 17 hours later on average in women taking these medications, which may not be clinically important. Breastfeeding support can help if feeding is difficult.

Talk to Your Prescriber

Find a perinatal mental health therapist

If you have thoughts of harming yourself, call or text 988, or call or text the National Maternal Mental Health Hotline at 1-833-TLC-MAMA (1-833-852-6262).

Frequently Asked Questions

Is Lexapro safe during pregnancy?

Most studies have not found an increased risk of birth defects, and ACOG names escitalopram as a reasonable first-line choice if you have not taken an antidepressant before. Its pregnancy data are less extensive than sertraline’s.

Is Lexapro or Zoloft better during pregnancy?

ACOG lists both as reasonable first choices. Sertraline is often preferred because it has more safety research. If one has already worked for you, staying on it is usually recommended.

What pregnancy category is Lexapro?

It was formerly Category C. The FDA removed letter categories in 2015.

Can you take Lexapro while breastfeeding?

Yes. LactMed says escitalopram is not a reason to stop breastfeeding. Watch younger babies for unusual sleepiness or poor feeding.

Should I switch from Lexapro to Zoloft for breastfeeding?

Generally no. If escitalopram kept you stable during pregnancy, ACOG advises not changing medications after birth.

PostpartumDepression.org Team
Written by:

Jenna Carberg was diagnosed with postpartum depression following the birth of her daughter in 2016. It was a healthy birth but in the following days, Jenna's mood changed quickly. Doctors suggested that it might be the "baby blues", but her husband Chris suggested she seek a second opinion. Jenna was diagnosed with postpartum depression and began a journey that lasted 9 long months with significant ups and downs. Jenna's mental health care and her experiences became a passion for her to share with the world. She and her husband Chris founded PostpartumDepression.org as a support website designed to help women suffering in silence and their loved ones.

  1. American College of Obstetricians and Gynecologists. “Treatment and Management of Mental Health Conditions During Pregnancy and Postpartum: ACOG Clinical Practice Guideline No. 5.” Obstetrics & Gynecology. 2023;141(6):1262-1288. https://doi.org/10.1097/AOG.0000000000005202.
  2. Huybrechts KF, Palmsten K, Avorn J, et al. “Antidepressant Use in Pregnancy and the Risk of Cardiac Defects.” New England Journal of Medicine. 2014;370(25):2397-2407. https://doi.org/10.1056/NEJMoa1312828.
  3. Bérard A, Zhao JP, Sheehy O. “Antidepressant Use During Pregnancy and the Risk of Major Congenital Malformations in a Cohort of Depressed Pregnant Women: An Updated Analysis of the Quebec Pregnancy Cohort.” BMJ Open. 2017;7(1):e013372. https://doi.org/10.1136/bmjopen-2016-013372.
  4. Gao SY, Wu QJ, Sun C, et al. “Selective Serotonin Reuptake Inhibitor Use During Early Pregnancy and Congenital Malformations: A Systematic Review and Meta-Analysis of Cohort Studies of More Than 9 Million Births.” BMC Medicine. 2018;16(1):205. https://doi.org/10.1186/s12916-018-1193-5.
  5. Huybrechts KF, Bateman BT, Palmsten K, et al. “Antidepressant Use Late in Pregnancy and Risk of Persistent Pulmonary Hypertension of the Newborn.” JAMA. 2015;313(21):2142-2151. https://doi.org/10.1001/jama.2015.5605.
  6. Grigoriadis S, VonderPorten EH, Mamisashvili L, et al. “The Effect of Prenatal Antidepressant Exposure on Neonatal Adaptation: A Systematic Review and Meta-Analysis.” Journal of Clinical Psychiatry. 2013;74(4):e309-e320. https://doi.org/10.4088/JCP.12r07967.
  7. Suarez EA, Bateman BT, Hernández-Díaz S, et al. “Association of Antidepressant Use During Pregnancy With Risk of Neurodevelopmental Disorders in Children.” JAMA Internal Medicine. 2022;182(11):1149-1160. https://doi.org/10.1001/jamainternmed.2022.4268.
  8. Sujan AC, Rickert ME, Öberg AS, et al. “Associations of Maternal Antidepressant Use During the First Trimester of Pregnancy With Preterm Birth, Small for Gestational Age, Autism Spectrum Disorder, and Attention-Deficit/Hyperactivity Disorder in Offspring.” JAMA. 2017;317(15):1553-1562. https://doi.org/10.1001/jama.2017.3413.
  9. Cohen LS, Altshuler LL, Harlow BL, et al. “Relapse of Major Depression During Pregnancy in Women Who Maintain or Discontinue Antidepressant Treatment.” JAMA. 2006;295(5):499-507. https://doi.org/10.1001/jama.295.5.499.
  10. MotherToBaby | Fact Sheets. Organization of Teratology Information Specialists (OTIS); NCBI Bookshelf. “Citalopram | Escitalopram (Celexa® | Lexapro®).” https://www.ncbi.nlm.nih.gov/books/NBK582639/. Accessed September 15, 2026.
  11. Drugs and Lactation Database (LactMed®). National Institute of Child Health and Human Development; NCBI Bookshelf. “Escitalopram.” https://www.ncbi.nlm.nih.gov/books/NBK501275/. Accessed September 15, 2026.
  12. U.S. Food and Drug Administration. “Pregnancy and Lactation Labeling Resources.” https://www.fda.gov/drugs/labeling-information-drug-products/pregnancy-and-lactation-labeling-resources. Accessed September 15, 2026.
  13. U.S. Food and Drug Administration. “Questions and Answers on the Pregnancy and Lactation Labeling Rule.” https://www.fda.gov/drugs/labeling-information-drug-products/questions-and-answers-pregnancy-and-lactation-labeling-rule. Accessed September 15, 2026.
  14. U.S. Food and Drug Administration. “Lexapro (escitalopram oxalate) Prescribing Information, 2009.” https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021323s032,021365s023lbl.pdf. Accessed September 15, 2026.
  15. National Library of Medicine. “Escitalopram. Drugs and Lactation Database (LactMed®).” https://www.ncbi.nlm.nih.gov/books/NBK501275/. Accessed September 15, 2026.
  16. Sriraman NK, Melvin K, Meltzer-Brody S; Academy of Breastfeeding Medicine. “ABM Clinical Protocol #18: Use of Antidepressants in Breastfeeding Mothers.” Breastfeeding Medicine. 2015;10(6):290-299. https://doi.org/10.1089/bfm.2015.29002.
  17. Marshall AM, Nommsen-Rivers LA, Hernandez LL, Dewey KG, Chantry CJ, Gregerson KA, Horseman ND. “Serotonin Transport and Metabolism in the Mammary Gland Modulates Secretory Activation and Involution.” The Journal of Clinical Endocrinology & Metabolism. 2010;95(2):837-846. https://doi.org/10.1210/jc.2009-1575.
  18. Neuman G, Colantonio D, Delaney S, Szynkaruk M, Ito S. “Bupropion and Escitalopram During Lactation.” The Annals of Pharmacotherapy. 2014;48(7):928-931. https://doi.org/10.1177/1060028014529548.